Michael R Merson Net Worth & Insider Trades

Michael R Merson - Director, Aspenbio Pharma, Inc

As of July 3, 2012

What is Michael R Merson's Net Worth?

The current estimated net worth of Aspenbio Pharma, Inc's Director, Michael R Merson, is estimated to be about $15.39K . Michael R Merson owns about 1,180 units of Aspenbio Pharma, Inc common stock. In the last 3 years at Aspenbio Pharma, Inc, Michael R Merson has sold an estimated value of $0 worth.

What is Michael R Merson's Past Insider Trading?

Michael R Merson's largest purchase order was 1,100 units , worth over $3.13K on August 11, 2009. In total, Michael R Merson has made about 7 transactions over 3 years of their time at Aspenbio Pharma, Inc. Michael R Merson usually trades in January, with the busiest year in 2009. The most recent transaction was a purchase order of 1,000 units , worth over $1.92K on July 3, 2012.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Michael R Merson

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Michael R Merson's' Mailing Address?

  • Mailing address is 6308 North Charles Street Baltimore MD 21212 MD

What are Aspenbio Pharma, Inc's Past Insider Trades?

Aspenbio Pharma, Inc's most recent insider trade came on December 2, 2016 by Barry Honig who bought 29,815 units worth $150.26K . In the last 9 years, insiders at Aspenbio Pharma, Inc have sold an estimated value of $682.38K and bought an estimated value of $569.99K worth of shares. Insider trading is most common in January, with the busiest year in 2012. The most active traders at the company are Douglas I Hepler, Director,  Jeffrey McGonegal, Chief Financial Officer,  and Gail Schoettler, Director .

Bioptix, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...